CLINEXEL Life Sciences at BIOASIA 2026, Hyderabad
CLINEXEL Life Sciences participated in BIOASIA 2026, held on 17–18 February 2026 in Hyderabad, a premier gathering of the biotech, pharmaceutical, and life sciences ecosystem, bringing together global leaders, emerging biotech innovators, investors, and policymakers to discuss the future of healthcare and innovation in India.
The conference provided a platform for discussions around biotechnology innovation, clinical research, regulatory pathways, and the future of global healthcare collaboration.
Our leadership team, including:
- Dr. Deepa Arora, CEO
- Dr. Mukesh Kumar, CSO
- Dr. Ranjit Chavan, Head of Pharmacovigilance
actively engaged with attendees at Booth #25, sharing expertise in:
- Early-phase clinical strategy
- Regulatory pathways
- Risk-mitigated clinical trial execution
- Accelerating clinical development timelines across India and global markets
The conference featured insightful panel discussions, forward-looking conversations, and collaborative networking, reflecting the growing confidence in India’s life sciences and clinical research environment.
CLINEXEL’s presence provided a platform for meaningful stakeholder interactions, enabling discussions on:
- Integrated clinical research
- Regulatory support
- Pharmacovigilance solutions
- Global clinical development strategies
tailored to global quality and compliance standards.
CLINEXEL continues to support pharmaceutical, biotechnology, and medical device companies through scientifically driven clinical research, regulatory expertise, pharmacovigilance support, and globally aligned clinical development solutions.